Jerry Phillips, MD
Family Medicine · Bainbridge, GANPI 1134133523
Payments from drug & device makers
Across 168 payments — averaging $16.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$384
- Kowa Pharmaceuticals America, Inc.$274
- Pfizer$226
- Novo Nordisk$223
- GSK$195
- Teva Pharmaceuticals USA, Inc.$174
- plus $1K from 26 others
What the payments were for
- Food & beverage$2,835100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 24 | $384 |
| Kowa Pharmaceuticals America, Inc. | 18 | $274 |
| Pfizer | 12 | $226 |
| Novo Nordisk | 12 | $223 |
| GSK | 10 | $195 |
| Teva Pharmaceuticals USA, Inc. | 13 | $174 |
| AstraZeneca | 10 | $161 |
| Exact Sciences | 8 | $156 |
| Lilly USA, LLC | 8 | $131 |
| Novartis | 4 | $102 |
| Amgen | 5 | $85 |
| Merck | 5 | $79 |
| Astellas Pharma US Inc | 5 | $78 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $64 |
| Bayer | 3 | $60 |
| Eisai Inc. | 3 | $49 |
| Lundbeck LLC | 2 | $47 |
| Biohaven Pharmaceuticals, Inc. | 3 | $38 |
| Corcept Therapeutics | 2 | $37 |
| Avanir Pharmaceuticals, Inc. | 2 | $33 |
| Arbor Pharmaceuticals, Inc. | 2 | $33 |
| Sanofi-aventis U.S. LLC | 2 | $30 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $25 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $22 |
| Ardelyx, Inc. | 1 | $21 |
| Upsher-smith Laboratories LLC | 1 | $18 |
| Johnson & Johnson | 1 | $17 |
| Idorsia Pharmaceuticals US Inc | 1 | $17 |
| Xeris Pharmaceuticals, Inc. | 1 | $15 |
| Ironwood Pharmaceuticals, Inc | 1 | $14 |
| Amarin Pharma, Inc. | 1 | $14 |
| Philips North America LLC | 1 | $14 |
How this compares
$2,835 in reported general payments places this provider in the 75th percentile of 3,111 family medicine providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 147 | $89,159 |
| JardianceEmpagliflozin | 131 | $73,936 |
| OzempicSemaglutide | 67 | $68,951 |
| LinzessLinaclotide | 68 | $48,023 |
| FarxigaDapagliflozin Propanediol | 68 | $36,369 |
| MyrbetriqMirabegron | 50 | $21,964 |
| Nurtec OdtRimegepant Sulfate | 26 | $21,193 |
| XareltoRivaroxaban | 16 | $19,473 |
| MounjaroTirzepatide | 15 | $14,824 |
| TrintellixVortioxetine Hydrobromide | 23 | $14,001 |
| EntrestoSacubitril/Valsartan | 29 | $13,593 |
| Dexlansoprazole DrDexlansoprazole | 56 | $11,867 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 18 | $11,434 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 418 | $11,164 |
| Breo ElliptaFluticasone/Vilanterol | 29 | $10,928 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis, Nurtec Odt | $226 | $110,353173 claims |
| Novo NordiskOzempic | $223 | $68,95167 claims |
| AstraZenecaFarxiga, Breztri Aerosphere, Symbicort | $161 | $51,050100 claims |
| AbbVieLinzess | $384 | $48,02368 claims |
| GSKBreo Ellipta, Shingrix, Arexvy | $195 | $24,94388 claims |
| Astellas Pharma US IncMyrbetriq | $78 | $21,96450 claims |
| Johnson & JohnsonXarelto | $17 | $19,47316 claims |
| Lilly USA, LLCMounjaro | $131 | $14,82415 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $25 | $14,00123 claims |
| NovartisEntresto | $102 | $13,59329 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 3,111 family medicine providers in Georgia.
Other family medicine in Bainbridge
- Joseph SurberColumbus$16.6M
- Angela RitterGainesville$15.8M
- Jeffrey KingsleyColumbus$8.1M
- Christopher OldfieldSavannah$6.4M
- Darrell MurrayAtlanta$3.9M
- Ben ThomasAtlanta$3.2M
- Debbie HaginsSavannah$2.1M
- Aziz PiraniLilburn$2.1M
- Nadia CameronAtlanta$2.1M
- John LentzSnellville$1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.